Pure Global
NCT06157736

Microbiome in the Acute Stage of New Onset Paediatric Type 1 Diabetes

University College Cork·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes
Study type
Observational
Sponsor & location
Primary sponsor
University College Cork
Location
Cork, Ireland
Timeline & enrollment
Phase
N/A
Start date
Oct 06, 2023
End date
Aug 31, 2025
Enrollment
100 participants
Primary outcome

Describe evolution of the microbiome and metabolome during the early stages of new onset T1D

Summary

The goal of this observational study is to learn more about the microbiome and metabolome of
 children with type 1 diabetes (T1D). The main questions it aims to answer are:
 
 1. Do the microbiome and metabolome play a role in the onset and presentation of T1D?
 
 2. How do the microbiome and metabolome evolve during the early stages of T1D?
 
 3. Are there are differences in the microbiome or metabolome of children who present with
 diabetic ketoacidosis (DKA) versus those who present without DKA, and between those who
 present with mild, moderate or severe DKA?
 
 4. Is there an association between the microbiome or metabolome and glycaemic control
 during the first year of diagnosis?

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06157736
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06157736 through Pure Global AI's free database. This phase not specified trial is sponsored by University College Cork and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.